The prevalence and consequences of support for off-label Ozempic prescriptions

Ozempic and related semaglutide drugs represent a popular new strategy to address obesity in the United States, yet uptake of these medications has sparked opposition highlighting concerns about off-label drug use policies, drug safety, supply shortages and cost. Public attitudes towards off-label p...

Full description

Saved in:
Bibliographic Details
Published in:Health economics, policy and law policy and law, 2025-10, Vol.20 (4), p.330-343
Main Authors: Callaghan, Timothy, Motta, Matthew, Stein, Michael, Goidel, Kirby
Format: Article
Language:English
Subjects:
Adults
Attitudes
Drug abuse
Drugs
GLP-1
GLP-1 receptor agonists
Health care expenditures
Labeling
Obesity
Off-label
off-label prescribing
Ozempic
Pharmaceutical industry
Physicians
Polls & surveys
Prescribing
Prescription drugs
Public opinion
Respondents
Rhetoric
Safety
Shortages
Uptake
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!